<?xml version='1.0' encoding='UTF-8'?>
<quiz><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Threshold values of International Association of Diabetes and Pregnancy Study Group Consensus Panel for diagnosis of gestational diabetes mellitus</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_55852</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Fasting plasma gluosa 92 mg/dl or 5.1 mmol/L</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>1-hr 75 gr OGTT 153 mg/dl or 8.5 mmol/L</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>2-hr 75 gr OGTT 180 mg/dl or 10.0 mmol/L</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>A1C 6,8%</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of these statements is true about diabetic retinopathy?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_55853</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Retinal deteriotation may occur during pregnancy in patients who have background retinopathy before pregnancy</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Diabetic patients with no evidence of retinopathy before pregnancy could get rid of developing retinopathy during pregnancy</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>All patients with active proliferative retinopathy in pregnancy should undergo cesarean delivery in order to avoid the risk of vitreous hemorrhage related to vaginal delivery</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Poor glycemic control does not respond to progression of diabetic retinopathy in pregnancy</p>

<p> </p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following findings are considered diagnostics for overt diabetes in pregnancy?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_55855</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Hemoglobin A1c >6%</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Glucosuria on urine dip</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Fasting plasma glucose <font face="Symbol"> equal to or greater than</font> 120 mg/dl</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Random plasma glucose <font face="Symbol">equal to or greater than</font> 200 mg/dl</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Compare to women without diabetes, which fetal condition occurs more often in the setting of pregestational diabetes?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_55856</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Stillbirth</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Perinatal death</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Postpartum hemorrhage</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Gestational hypertension</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 23 year old G1P0 at 38 weeks gestation, delivered a 3,9 kg baby vaginally. Upon delivery of the placenta, there was notes to be an inverted uterus, which was successfully managed including replacement of the uterus. Which of the following placental implantation sites would most likely predispose to an inverted uterus ? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28874</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Fundal</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Anterior</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Posterior</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Lateral</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Lower segment</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 25 year old patient tell her doctor that she wants to have a child in the next few year. She is concerned as she has seizure disorder and taken valproic acid. It has been 1 year since her last seizure and she has heard that seizures are dangerous for the fetus. 2. Which of the following antiseizure medication, when taken as monotherapy, is associated with the highest of major congenital malformation ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28880</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin-bottom:0cm"><span style="line-height:normal">Phenytoin</span></p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p style="margin-bottom:0cm; margin-left:54pt"><span style="line-height:normal">Valproic Acid</span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin-bottom:0cm"><span style="line-height:normal">Phenobarbital</span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Carbamazepine</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 29 year old G2P1 at 28 weeks gestation, who had normal hemoglobin level 4 weeks ago at her first prenatal visit complains of 1 week of fatique and now has hemoglobin level of 7,0 g/dL She noted dark colored urine after taking an antibiotic for urinary tract infection. Which of the following is the most likely diagnosis ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28873</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Iron deficiency anemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Thalasemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Hemolysis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Folate deficiency</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>vitamin B12 deficiency</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 39-year-old G2P1001 presents at 18–5/7 weeks’ gestation for her scheduled fetal anatomic survey. During the examination, the fetal anatomy is noted to be normal, but the cervical length is measured at 15 mm. Despite counseling about the lack of consistent data showing a benefit in this setting, the patient requests that a cervical cerclage be placed. Which of the following, if present, would be considered an absolute contraindication to cervical cerclage placement?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28884</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Advanced maternal age</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Prolapse of fetal membranes into the vagina</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Positive fetal fibronectin test</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Rupture of fetal membranes</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>E Placenta previa</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A monochorionic twin pregnancy showed a discordant crown–lump length (CRL) at 12 weeks gestation, and a discordant amniotic fluid volume at 15 weeks with a deepest vertical pocket of 1.8 cm in the smaller twin and 6.3 cm in the larger twin. Both bladders are visible. Which of the following is/are likely diagnosis(es)?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28882</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Unequal placental sharing.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> Twin-to-twin transfusion syndrome Quintero Stage II.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Complicated monochorionic twin pregnancy, suspected to develop either selective fetal growth restriction or twin–twin transfusion syndrome (TTTS).</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> Velamentous cord insertion in one twin.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Physiological variation.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A patient presents for her first prenatal visit at 10 weeks’ gestation. Her routine prenatal intake laboratory tests reveal that she is not immune to rubella. What should you recommend?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28887</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Administer MMR vaccination now</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Administer MMR vaccination at 28 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Administer MMR vaccination postpartum</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>She does not need MMR vaccination</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Chorioamnionitis (intra-amniotic infection) is typically caused by which of the following organisms?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28888</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Group B β-hemolytic streptococcus (GBS)</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Escherichia coli</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Staphylococcus aureus</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Ureaplasma urealyticum</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Multiple pathogens</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Congenital syndromes related to viral infections are most likely to occur if the mother contracts the illness during which of the following trimesters?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28883</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>In the first trimester</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>In the second trimester</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>In the third trimester</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Postpartum</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>During childbirth</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Intakes of vitamin A during pregnancy have not been associated with birth defects when it is given in doses ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28889</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Less than 100 IU per day.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>More than 100 IU per day</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Less than 10.000 IU per day</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>More than 10.000 IU per day</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>More than 20.000 IU per day</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Maternal deficiency of vitamin D has been associated with which of the following complications in the offspring?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28892</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Anemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Jaundice</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Seizures</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Congenital rickets</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>The following antihypertensive agents are used in pregnancy except:</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28875</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Angiotensin-converting enzyme inhibitors</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hydralazine</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>labetalol</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Methyldopa</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Nifedipine</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which is true of Hepatitis B in pregnancy?      </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28876</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Breastfeeding is always contraindicated in women who are chronic carriers of </span></span></span></span></span></span></span><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">HBV.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 36pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Non-immune mothers should not be vaccinated after the second trimester.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 36pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">The risk of fetal infection is higher if maternal infection occurs in the third trimester.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 36pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Only infants with HBV positive mothers should be vaccinated.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following vitamins, when combined with the antihistamine doxylamine, has been found to be helpful in cases of nausea and vomiting?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28891</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p> Vitamin C</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Vitamin D</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Vitamin B6</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Vitamin B12</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Kelainan kromosom seperti trisomi 21 terjadi pada fase ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28890</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>GAMETOGENESIS</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> STADIUM 2 SEL</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>MORULA</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>BLASTULA</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> GASTRULA</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Methods of prenatal testing for congenital abnormalities – which of the following are true?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28881</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Nuchal translucency (the space between skin and soft tissue overlying the cervical spine), measured between 11 and 13+6 weeks, is a screening test for chromosomal abnormalities such as trisomy 18.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>When the fetus has an open neural tube defect (NTD), maternal serum AFP levels are usually raised. As such, this can be used as a diagnostic test for NTD.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Amniocentesis is safer than CVS before 12 weeks.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Structural abnormalities are usually diagnosed at 12 weeks at the ‘anomaly scan’.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Chorionic villus sampling (CVS) usually allows an abnormal fetus to be identified at 16 weeks.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following is true in regards to Toxoplasmosis?  </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28877</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 18pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Indoor cats are not reservoirs for Toxoplasmosis.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 18pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Only HIV positive women should be screened for Toxoplasma.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 18pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">15% of reproductive age women have antibodies to Toxoplasmosis.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 18pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">Spiramycin may reduce risk of fetal transmission.</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 18pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">ALL of the above are TRUE</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Your patient is a 40-year-old G3P2 obese woman at 37 weeks gestation. Her pregnancy has been complicated by insulin-requiring gestational diabetes. Her most recent Hgb A1c was 6.0. The patient reports that her fasting and postprandial sugars have all been within normal range. Her fetus has an estimated weight of 2950 grams by Leopolds today. All of the following are correct ways to manage this patient except</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28878</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 0cm 36pt; text-align:justify"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><b><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">The patient should undergo an elective cesarean section at 38 weeks to avoid shoulder </span></span></b></span></span></span></span></span><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><b><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">dystocia</span></span></b></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>The patient should be induced by 40 weeks if spontaneous labor does not occur</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>After 6 weeks postpartum, the patient should undergo a 75-g glucose tolerance test</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 0cm 36pt; text-align:justify"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="font-family:"Times New Roman", serif">In the postpartum period, it is acceptable to use oral contraceptives</span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p style="margin:0cm 0cm 10pt 36pt; text-align:justify"><span style="font-size:11pt"><span style="line-height:16.866666793823242px"><span style="font-family:Calibri, sans-serif"><span style="caret-color:#000000"><span style="color:#000000"><span lang="EN-SG" style="font-size:12pt"><span style="line-height:18.399999618530273px"><span style="font-family:"Times New Roman", serif">A glucose infusion will be given to the patient in labor</span></span></span></span></span></span></span></span></p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 25 year old nulliparous patient with HIV wishes to become pregnant. Which of the following is true?  </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_29247</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Even with appropriate antiretroviral therapy, neonatal infection occurs 20-25% of the time.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Fetal scalp electrode monitoring should be avoided.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>With appropriate antiretroviral therapy, breastfeeding is safe in these patients.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>If the mother is untreated and has a high viral load, pursue a vaginal delivery</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 32-year-old woman primigravida who is 34 weeks pregnant attends the antenatal clinic complaining of severe itching.Serum bile acids are found to be elevated and she is diagnosed with obstetric cholestasis.What is the most effective medication to improve her itching? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_29243</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Activated charcoal</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Chlorphenamine</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Colestyramine</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>S-adenosyl methionine</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Ursodeoxycholic acid</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>According to WHO, anemia in pregnancy is diagnosed, when hemoglobin is less than :</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28898</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p> 8 gr%</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>9  gm%</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>10  gm%</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>11 gm%</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>12  gm%</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Ascending infection of the vagina can induce premature labour. Which pathogen ismost commonly associated with bacterial vaginosis ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28902</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Candida albicans</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Chlamydia trachomatis</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Gardnerella vaginalis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Listeria monocytogenesis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Neisseria meningitis</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A women with severe ankle sprain was prescribed ibuprofen for 72 hours. At what gestational age should she avoid this medication? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_29250</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Any gestational age</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Before 12 weeks and after 26 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> after 36 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>after 32 weeks</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p> during lactation</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Commonenst congenital malformation in infant of a diabetic mother is :</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_28900</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Neural tube defect</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hydrocephalus</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Higroma colli</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Sacral agenesis</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>You are asked to update your unit guidelines on antenatal aspirin. Which of the following patients should have aspirin 75 mg daily from 12weeks’ gestation? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_29239</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p> 23-year-old primigravida with a BMI of 36 at booking.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>32-year-old para 1 whose mother developed preeclampsia at 27 weeks gestation</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>34-year-old para 1 with a BMI of 34 at booking who developed gestational diabetes in her previous  pregnancy.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>39-year-old para 1 (previous unexplained stillbirth at 36 weeks’ gestation</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> 39-year-old para 1 (who delivered an SGA baby at 35 weeks, 12 years ago</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>With reference to iron deficiency anaemia in pregnancy, except? </p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_29241</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Iron demand in pregnancy increases to 4 mg per day.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>High levels of serum ferritin confirm the diagnosis.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> It is more common in multiple pregnancy.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>It is usually treated with oral iron.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> Blood transfusion should be avoided.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following autoantibodies are specific for lupus?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56384</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Anti- double-strande d-DNA and anti-Ro</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Anti- double-stranded -DNA and anti-La</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Anti-Smith and anti-RNP</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Anti-Smith and Anti-double-stranded -DNA</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A patient presents for preconceptional counseling with a history of systemic lupus erythematosus (SLE). She was diagnose as an plescent but has one well during the past few years an is currently in remission. Following counseling, the patient would  like to pursue pregnancy. What is the most common complication that she will likely encounter uring her pregnancy?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56385</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Anemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Preeclampsia</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Deep-vein thrombosis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>. Fetal-growth restriction</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Ninety-five percent of patients with systemic lupus erythematosus experience all EXCEPT which of the following clinical manifestations?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56386</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Fever</p>

<p> </p>

<p> </p>

<p>d. Weight loss</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Arthralgias</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Proteinuria</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Weight loss</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>What condition is described by a low serum free thyroxine level and normal thyroid-stimulating hormone values?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56401</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Isolated hypothyroxinemia</p>

<p> </p>

<p> </p>

<p>d. Subclinical hyperthyroidism</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Isolated hyperthyroxinemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Subclinical hypothyroidism</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Subclinical hyperthyroidism</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>An increased incidence of which of the following pregnancy outcomes have been linked with maternal subclinical hypothyroidism?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56402</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Stillbirth</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Preeclampsia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Placenta previa</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>None of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Ms. Smith is diagnosed with gestational diabetes that is controlled solely with diet. Which of the following are important for the management of her pregnancy at term?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56404</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Induction at 38 weeks’ gestation</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Weekly umbilical artery Doppler studies</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Cesarean delivery if the estimated fetal weight is</p>

<p>4250 g</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>None of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following reflects the American College of Obstetricians and Gynecologists (ACOG) recommendations concerning activity in gravidas with gestational diabetes?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56405</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Modified bed rest near term</p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Moderate exercise for those without</p>

<p>contraindications</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Maintenance of the same exercise routine</p>

<p>established before conception</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>None of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>The incidence of stillbirth is highest in pregnancies complicated by which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56436</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Overt diabetes</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gestational diabetes</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Overt diabetes and hypertension</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gestational diabetes and hypertension</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Reported by Landon (2009), the Maternal-Fetal Medicine Units Network evaluated women with mild gestational diabetes, defined as a fasting blood glucose level > 95 mg/dL. Compared with women receiving only standard obstetrical care, those receiving dietary counseling and glucose monitoring had decrease</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56437</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Fetal macrosomia</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Cesarean delivery</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Shoulder dystocia</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>All of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Results from randomized controlled trials suggest what benefit is gained from low-dose aspirin use during pregnancy in women with chronic hypertension?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56438</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>No benefit</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> Reduced preterm birth rates</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Reduced maternal mortality rates</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Reduced fetal-growth restriction rates</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A 30-year-old G3P2 presents for prenatal care. Her prior pregnancies have both been complicated by mild gestational hypertension near term. She is currently 12 weeks pregnant, and her blood pressure is 146/88 mm Hg. Which of the following is the most appropriate next step in her management?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56441</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Continued observation</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Begin treatment with methyldopa</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Begin treatment with hydrochlorothiazide</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>None of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Compared with normal-weight patients, obese women have increased rates of all EXCEPT which of the following?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56447</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Hypertension</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Wound infection</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Vaginal delivery</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gestational diabetes</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Regarding cesarean delivery in obese women, which of the following should be done to reduce the chances of wound disruption?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56449</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Vertical skin incision</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Weight loss during the pregnancy</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Closure of the subcutaneous layer</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>All of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>The rate of which of the following is not increased in fetuses of obese pregnant women?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56451</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Stillbirths</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Heart defects</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Renal agenesis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Neural-tube defects</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>A pregnant patient with chronic hypertension develops superimposed preeclampsia. She is diagnosed with pulmonary edema on the first postpartum day. Which of the following statements regarding this complication is true?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56457</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Her edema may be cardiogenic.</p>

<p> </p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Her edema may be related to increased capillary permeability.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Brain natriuretic peptide levels are less</p>

<p>informative in pregnant patients compared with</p>

<p>levels in nonpregnant patients.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>All of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>What is the best way to increase oxygen delivery to peripheral tissues in an obstetrical patient with hemorrhage that is complicated by acute respiratory distress syndrome?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56459</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Blood transfusion</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Intravenous antibiotics</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>High-frequency oscillation ventilation</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Oxygen therapy to increase arterial Po2 to</p>

<p>200 mm Hg</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>The recipient cotwin in a monochorionic twin gestation affected by twin-twin transfusion syndrome may experience all EXCEPT which of the following neonatal complications?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56461</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Thrombosis</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Hypovolemia</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kernicterus</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Heart failure</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following is the most important predictor of neurological outcome of the survivor after death of a cotwin?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56462</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Chorionicity</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gestational age at time of demise</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Malformations present in the deceased twin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Length of time between demise and delivery of</p>

<p>survivor</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following statements is true in twinreversed- arterial-perfusion (TRAP) sequence?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56463</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>shunt.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>The donor is at risk of cardiomegaly and highoutput</p>

<p>heart failure.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>The most effective treatment is injection of KCl</p>

<p>into the recipient twin.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Placental arterial perfusion pressure in the</p>

<p>recipient exceeds that of the donor.</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Compared with singleton pregnancies, multifetal gestations have a higher risk of all EXCEPT which of the following complications?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56464</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Preeclampsia</p>

<p> </p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hysterectomy</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Maternal death</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Postterm pregnancy</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following is true regarding oligohydramnios?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56547</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>It is associated with fetal-growth restriction.</p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>It is associated with congenital fetal</p>

<p>malformations.</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p> It is associated with a higher cesarean delivery</p>

<p>rate.</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p> All of the above</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Which of the following sonographic assessments of fetal-growth restriction is the most predictive of obstetrical outcome?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56549</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Biometric growth < 3rd percentile</p>

<p> </p>

<p> </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Biometric growth < 5th percentile</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Biometric growth < 3rd percentile and abnormal</p>

<p>umbilical artery Doppler velocimetry results</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Biometric growth < 5th percentile and absent</p>

<p>end-diastolic flow noted during umbilical artery</p>

<p>Doppler velocimetry study</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 35 tahun, G2P1A0, dengan usia kehamilan 10 minggu datang ke poliklinik untuk memeriksakan kehamilannya. Ibu cemas karena kehamilannya yang pertama bayi lahir dengan kelainan bawaan lahir dan akhirnya meninggal. Dari anamnesis didapatkan bahwa ayah kandung dari ibu meninggal karena penyakit ginjal akibat komplikasi penyakit kencing manis. Pada pemeriksaan fisik : tanda vital dalam batas normal, sklera dan ikterus kesan normal. Pemeriksaan apakah yang perlu dilakukan pada ibu sebagai metode skrining pada kasus ini ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56647</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>One-step approach Tes Toleransi Glukosa Oral</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Two-step approach Tes Toleransi Glukosa Oral</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gula Darah Sewaktu</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gula Darah Puasa</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Glycated Hemoglobin</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 35 tahun, G2P1A0, dengan usia kehamilan 10 minggu datang ke poliklinik untuk memeriksakan kehamilannya. Ibu cemas karena kehamilannya yang pertama bayi lahir dengan kelainan bawaan lahir dan akhirnya meninggal. Dari anamnesis didapatkan bahwa ayah kandung dari ibu meninggal karena penyakit ginjal akibat komplikasi penyakit kencing manis. Pada pemeriksaan fisik : tanda vital dalam batas normal, sklera dan ikterus kesan normal. Jika hasil uji pemeriksaan penunjang lanjutan bernilai di atas nilai ambang, apakah diagnosis paling tepat dari kasus di atas ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56648</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Diabetes Mellitus Tipe 1</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Diabetes Mellitus Tipe 2</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Diabetes Mellitus Tipe Spesifik</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Diabetes Mellitus Gestasional</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Diabetes Mellitus Pregestasional</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 35 tahun, G2P1A0, dengan usia kehamilan 10 minggu datang ke poliklinik untuk memeriksakan kehamilannya. Ibu cemas karena kehamilannya yang pertama bayi lahir dengan kelainan bawaan lahir dan akhirnya meninggal. Dari anamnesis didapatkan bahwa ayah kandung dari ibu meninggal karena penyakit ginjal akibat komplikasi penyakit kencing manis. Pada pemeriksaan fisik : tanda vital dalam batas normal, sklera dan ikterus kesan normal. Masuk dalam kategori apakah kasus tersebut, berdasarkan selective screening criteria?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_56649</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Tidak terklasifikasi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Risiko rendah</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Risiko sedang</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Risiko tinggi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Tidak berrisiko</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 20 tahun, G1P0A0, dengan usia kehamilan 20 minggu 4 hari datang ke Puskesmas untuk memeriksakan kehamilannya. Ibu membawa hasil pemeriksaan USG yang dilakukan 2 hari sebelumnya : kehamilan kembar dua, intrauterin, hidup, dengan jenis kelamin Fetus 1 laki-laki dan Fetus 2 perempuan dalam keadaan normal.  Berdasarkan hasil temuan USG, diagnosis apa yang paling mungkin untuk kasus ini ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57211</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Monokorion – Monoamnion</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Monokorion-Diamnion</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Dikorion-Diamnion</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kembar monozigot</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Kembar Dizigot</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 25 tahun, G2P1A0, dengan usia kehamilan 28 minggu 2 hari datang ke Puskesmas untuk kunjungan ketiga memeriksakan kehamilannya. Riwayat anak pertama lahir dengan berat badan 4200 gram. Kadar gula darah skrining : puasa 112 mg/dL, 1 jam TTGO 195 mg/dL, 2 jam TTGO 165 mg/dL.</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57213</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Hiperinsulin janin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hiperinsulin ibu</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Hiperglikemia ibu</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hiperglikemia janin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hormon diabteogenik plasenta</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 29 tahun, G1P0A0, dengan usia kehamilan 12 minggu datang ke Klinik dengan keluhan demam disertai ruam makulopapuler dimulai dari wajah kemudian ke seluruh tubuh dan anggota gerak. Hasil pemeriksaan antibodi IgM Rubella positif. Komplikasi jangka panjang apakah yang dapat terjadi pada janin dari ibu ini ?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57215</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>DM Tipe 1</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Obesitas</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hipertensi</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Penyakit Jantung Koroner</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Aterosklerosis</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. 1. Pemeriksaan penunjang apakah yang paling tepat untuk menegakkan diagnosis kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57217</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Uji serologi HSV</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Uji Non-Treponemal </p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kultur spesimen</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Aviditas IgG</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Direct Immuno Floresecent</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. Apa etiologi kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57221</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Neisseria gonorhoe</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gardnerella vaginalis</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Clamydia trachomatis</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Treponema pallidum</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Toxoplasma gondii</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. Apakah antibiotik paling tepat untuk kasus ini?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57226</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="20.0" format="html"><text><![CDATA[<p>Penisilin G</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Metronidazol</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Ceftriaxon</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gentamisin</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Meropenem</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Perempuan, 22 tahun, G1P0A0, usia kehamilan 36-37 minggu, datang ke Puskesmas dengan keluhan demam, sakit kepala dan malaise. Riwayat luka di vagina sejak 6 minggu lalu, tidak nyeri. Pemeriksaan fisik : ruam kulit papula-skuomosa di telapak tangan dan telapak kaki, papul mengalami ulkus dengan dasar ulkus bersih di vagina, teraba pembesaran kelenjar inguinal bilateral. Komplikasi apa yang dapat terjai pada bayi?</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57231</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>Pneumonitis</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Kematian perinatal</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Kelainan jantung</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Hepatosplenomegali</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Tuli sensorineural</p>]]></text><feedback><text/></feedback></answer></question><question type="multichoice"><name><text>UJIAN FETOMATERNAL II PERIODE NOVEMBER 2020</text></name><questiontext format="html"><text><![CDATA[<p>Seorang perempuan, 35 tahun, G2P1A0, dengan usia kehamilan 10 minggu datang ke poliklinik untuk memeriksakan kehamilannya. Ibu cemas karena kehamilannya yang pertama bayi lahir dengan kelainan bawaan lahir dan akhirnya meninggal. Dari anamnesis didapatkan bahwa ayah kandung dari ibu meninggal karena penyakit ginjal akibat komplikasi penyakit kencing manis. Pada pemeriksaan fisik : tanda vital dalam batas normal, sklera dan ikterus kesan normal. Pemeriksaan apakah yang perlu dilakukan pada ibu sebagai metode skrining pada kasus ini ? - Copy</p>]]></text></questiontext><generalfeedback format="html"><text/></generalfeedback><defaultgrade>1</defaultgrade><penalty>0</penalty><hidden>0</hidden><idnumber>QST_57232</idnumber><single>true</single><answernumbering>abc</answernumbering><showstandardinstruction>0</showstandardinstruction><correctfeedback format="html"><text><![CDATA[<p>Your answer is correct.</p>]]></text></correctfeedback><partiallycorrectfeedback format="html"><text><![CDATA[<p>Your answer is partially correct.</p>]]></text></partiallycorrectfeedback><incorrectfeedback format="html"><text><![CDATA[<p>Your answer is incorrect.</p>]]></text></incorrectfeedback><shownumcorrect/><answer fraction="0.0" format="html"><text><![CDATA[<p>One-step approach Tes Toleransi Glukosa Oral</p>]]></text><feedback><text/></feedback></answer><answer fraction="20.0" format="html"><text><![CDATA[<p>Two-step approach Tes Toleransi Glukosa Oral</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gula Darah Sewaktu</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Gula Darah Puasa</p>]]></text><feedback><text/></feedback></answer><answer fraction="0.0" format="html"><text><![CDATA[<p>Glycated Hemoglobin</p>]]></text><feedback><text/></feedback></answer></question></quiz>